Evaluation of Combination Therapy With Oseltamivir and Zanamivir Versus Monotherapy in the Treatment of Virologically Confirmed Influenza in Primary Care a Randomised Double Blind Controlled Trial Study.

Trial Profile

Evaluation of Combination Therapy With Oseltamivir and Zanamivir Versus Monotherapy in the Treatment of Virologically Confirmed Influenza in Primary Care a Randomised Double Blind Controlled Trial Study.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 01 Feb 2013

At a glance

  • Drugs Oseltamivir (Primary) ; Zanamivir (Primary)
  • Indications Influenza A virus infections
  • Focus Therapeutic Use
  • Acronyms BIVIR
  • Most Recent Events

    • 09 Jul 2012 Last checked against European Clinical Trials Database record.
    • 01 Jan 2011 Results published in PLoS Medicine.
    • 30 Dec 2010 Planned end date changed from 1 May 2009 to 1 Nov 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top